Targeting fasting and post-prandial triglycerides

3' education - Sep. 1, 2013 - Snapshot 2013 - Dr. Joanne M. Donovan

Dr. Joanne Donovan, describes a potential novel approach to target fasting and post-prandial triglycerides with an oral agent that targets intestinal and liver PCSK9

Disclosure
Joanne M. Donovan MD PhD is Chief Medical Officer at Catabasis Pharmaceuticals, Inc